FDA OKs first coronavirus blood test, crucial for showing immunity and testing vaccines

April 2, 2020 / Elizabeth Weise, USA TODAY

The FDA has authorized the first test for coronavirus that measures antibodies in the blood. Such tests could identify people who have recovered from COVID-19, key for knowing who’s immune and developing a vaccine.

Cellex Inc. of Research Triangle Park, North Carolina received an emergency use authorization for its test Thursday from the Food and Drug Administration. It uses blood drawn from a vein to measure antibodies to the SARS-CoV-2 virus that causes COVID-19.

It is the first of an expected flood of such tests as companies race to develop them. Antibody tests are already being used in several countries, including China, South Korea and Singapore. 

“Antibody positivity likely means a person has recovered and can’t be reinfected. This test will be extremely valuable, especially for healthcare workers,” said Alan Wu, a professor of laboratory medicine at the University of California, San Francisco and chief of the clinical chemistry and toxicology laboratories at Zuckerberg San Francisco General Hospital. His team is testing several possible COVID-19 blood tests.


Print Friendly, PDF & Email

Mike Adams

Mike Adams is a medical device sales leader with extensive clinical experience in spine and biologics and a nationwide distribution network built over the last 10+ years in the industry. He has held various leadership positions in healthcare and device including Distributor Partner, Hospital COO and Spine VP of Sales. He currently leads the commercialization strategy for OrthoSpine Partners and is a Distributor Principal at Novel Medical. Because of his unique career path, Mike has the ability to see the healthcare business from multiple perspectives making him passionate about building strategic partnerships that help reduce overall costs, drive innovation, and cultivate growth for new markets.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button